PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

China Opens the Door to Personal Medicine Imports and Third-Party Online Platform Sales

A new Chinese law (in effect as of December 1, 2019) makes third-party online platform medicine sales legal, appropriately ends a draconian definition of counterfeit drugs, and effectively decriminalizes personal drug importation, but with a lot of gray! The changes were part of a major overhaul of the Drug Administrative Law of the People’s Republic of China (DAL). The previous linked to page is in Chinese but you can use Google translate to read it in English or another language. A summary in English can be found here:

Summary of Revised Chinese Drug Administration Law

For supporters of online access to safe and affordable imported medicines, this is kind of cool.

(more…)
Share
Tagged with: , ,

Happy Thanksgiving from the UN IGF in Berlin

Left to Right: Ron Andruff, Aria Ilyad Ahmad, Oki (Okiomiteni) Joy Olufuye, Gabriel Levitt.

I’m writing to you from Berlin, Germany on Thanksgiving and I’m missing my family. But it was important to be here. I came to attend and participate at the United Nations Internet Governance Forum (IGF). At the IGF, people from all over the world delve into an assortment of internet issues that impact the lives of people everywhere. Very broadly, the topics covered related to free speech, privacy, competition, security, child safety, nationalism, protecting democratic elections, and the reason I was here: discussing and promoting access to safe and affordable medicine on the Internet. Attendees and participants are affiliated with international governmental organizations, national governments, non-profit organizations, activists, businesses, journalists, and a wide array of policy professionals focused on internet governance.

What is internet governance? I like this definition from Georgia Tech School of Public Policy:

“Internet governance refers to the rules, policies, standards and practices that coordinate and shape global cyberspace.”

(more…)
Share
Tagged with: ,

Hitting Pause on Criticism of the FDA, Just for Today

The Food and Drug Administration (FDA) is just one agency out of the many that make up the United States Department of Health and Human Services and, from PharmacyChecker’s relatively small (non-regulatory) role of helping verify online pharmacies to protect public health, I’ve learned just how insanely massive its mandate is. I’ve also witnessed and participated in its criticism, and with good reason: the agency is not honest or forthcoming about personal drug importation, their regulatory process has been said to be “inherently biased” in terms of which drugs they choose to approve and their coziness with the pharmaceutical industry, among other things. Wikipedia has an extremely long page aptly called Criticism of the Food and Drug Administration, much of it having to do with its role with prescription drugs, and less so other sectors, such as food, tobacco and cosmetics.  

As my greater advocacy initiatives have worked to implore the FDA to bring more balance, commonsense and fairness to regulating and providing consumer education about personal imports of prescription drugs, I’ve realized that I should practice the same in how I talk about the FDA. So, without further ado, a moment of praise amongst the criticism:

(more…)
Share
Tagged with: , ,

Lower-Cost Imported Drugs Can Save Lives

Millions of people are dying because they are not getting the healthcare they need and that includes prescription drugs. New research has made a slam dunk case for why international online pharmacy options are needed urgently. We can’t allow drug companies to continue fooling the public about drug importation. 

A Gallup Poll survey announced yesterday found that 34 million Americans know someone who died because they could not afford medical treatments. That doesn’t mean prescription drug affordability specifically was the cause. In fact, the Gallup Poll lacks details about what kinds of medical treatments were too expensive. However, the poll identifies that a rising percentage of Americans are reporting going without prescriptions because of cost: from 18.9% in January to 22.9% in September of 2019. That would be about 58 million Americans who say they did not fill a prescription in the past 12 months because of cost. Since pharmacies in other countries charge much lower prices, and properly credentialed international online pharmacies make those drugs available, the veracity of the title of this blog post is undeniable.

(more…)
Share
Tagged with: , ,

Canadian Ambassador Says Canada’s Too Small For America’s Drug Import Program. Now What?

There are few people more supportive than I am of prescription drug importation as one policy to help Americans access lower drug prices. But, since I accuse Big Pharma types and the FDA of ignoring reality about the safety of personal drug imports from licensed pharmacies in Canada and other countries, I won’t ignore reality! Canada is concerned about momentum on drug importation coming from the Trump administration and states, particularly Florida, citing its relatively small population and limited drug supplies. The answer is not to pull back on importation, but to expand the scope of countries in the supply network. 

As reported in Reuters earlier this week, the Canadian Ambassador to the U.S. stated that she is “sympathetic to U.S. concerns regarding affordable prescription drugs.” On the other hand, she said, “Not only are we too small of a market, Canada cannot increase its domestic pharmaceutical drug supply to meet U.S. demand…” It’s not incredibly cynical of me to suggest that drug company lobbyists, who work internationally, have spoken with Canadian diplomats and said, “Look, we’re not going to increase your supply of far less expensive medicine just so Florida’s state importation plan can work and Trump can get a political win.” 

(more…)
Share
Tagged with: , ,

Recommended Reading: “The Toxic Nationalism of the Pharmaceutical Industry”

Photo by Element5 Digital on Unsplash

This week, I simply want to bring your attention to an article in The New Republic called “The Toxic Nationalism of the Pharmaceutical Industry.” Basically, the author Audrey Farley describes how the pharmaceutical industry has employed nationalism, racism, and prejudice in its communications and lobbying strategies that put profits over patients. To temper any hyperbolic mudslinging at the industry, overall, I note a disclaimer that most individuals working for drug companies are certainly no more biased or racist than other industries. My point is that Ms. Farley’s article just goes deeper in showing how disgusting and stupid the industry can actually be.

I’ll give two examples, the first I’ve written about before (but not as well). The Medicare Modernization and Prescription Drug Improvement Act of 2003 included legalizing the importation of lower-cost medicines from Canada, as long as the Secretary of Health and Human Services certified that the new imports would pose no additional safety risks and would yield substantial savings. The next year, someone from the Pharmaceutical and Researchers and Manufacturers of America (PhRMA) commissioned the writing of a fictional novel in which Muslim terrorists poison the drug supply in Canada to kill Americans who were buying lower-cost medicine from Canada.

(more…)
Share
Tagged with: ,